News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Masimo Corporation And Dolphin Medical, Inc. (OSIS) Announce Settlement Of Patent Dispute


4/27/2006 10:32:50 AM

IRVINE, Calif., April 27 /PRNewswire/ -- Masimo Corporation today announced that Dolphin Medical, Inc. has agreed that it will discontinue its Dolphin ONE product line. The discontinuation is part of an agreement between Dolphin and Masimo Corporation, in which Masimo has agreed to release Dolphin and its affiliates from certain patent infringement claims.

About Dolphin Medical, Inc.

Dolphin Medical, Inc. is an OEM manufacturer and distributor of pulse oximetry sensors and digital pulse oximetry instruments. In addition to being an OEM provider the company in 2003 entered into a North American distribution agreement with ConMed Corporation to distribute a complete line of Nellcor compatible sensors. The company is headquartered in Hawthorne, CA and also has manufacturing facilities in Jahor Bahru, Malaysia and Hawthorne, CA. For further information on the company and its complete range of products, please visit, www.dolphinmedical.com.

About Masimo

Masimo develops innovative monitoring technologies that significantly improve patient care -- helping solve "unsolvable" problems. In 1995, the company debuted Read-Through Motion and Low Perfusion pulse oximetry, known as SET, and with it virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. Over 70 independent clinical studies have confirmed that Masimo SET technology allows clinicians to accurately monitor blood oxygen saturation in critical care situations. In 2005 Masimo introduced Rainbow SET and with it, Pulse CO-Oximetry, which, for the first time, noninvasively monitors the level of carbon monoxide and methemoglobin in the blood, allowing early detection and treatment of potentially life-threatening conditions.

Masimo, founded in 1989, has the mission of "Improving Patient Outcome and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at www.masimo.com .

Masimo, SET, Signal Extraction Technology and Improving and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications are registered trademarks of Masimo Corp. Rainbow and Pulse CO-Oximetry are trademarks of Masimo Labs.

Contact: Brad Langdale

949-297-7009 blangdale@masimo.com

Masimo Corporation

CONTACT: Brad Langdale of Masimo Corporation, +1-949-297-7009,blangdale@masimo.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES